Comparing the effect of estradiol benzoate and 17ß-estradiol plus progesterone on follicular turnover and development, and pregnancy outcomes in a timed artificial insemination protocol.

The objective of this study was to compare the efficiency of estradiol benzoate (EB) and 17ß-estradiol (E2) associated with progesterone (P4) in a fixed-time artificial insemination (FTAI) protocol. We hypothesized that E2+P4 induces an earlier emergence of a new follicular wave (NFW), improving pre-ovulatory follicle diameter and pregnancy rates to FTAI (P/FTAI). In Exp.1, on Day 0 (D0), all Bos indicus cows (n = 12/group) received an intravaginal P4 device and a dose of PGF2α analogue. On D0, females were randomly assigned to receive EB or E2+P4. On D8.5, P4 intravaginal devices were removed and a dose of PGF2α and EB were administered in all females followed by fixed-timed AI on D10. Between D0 and D10, the dominant follicular growth was determined by ovary ultrasonography exams. On D8.5 and D10 the percentage of color power-Doppler signals in the dominant follicular wall was evaluated. In Exp. 2, 467 females (2-year-old nulliparous [n = 76], primiparous [n = 92] and pluriparous [n = 299]) were subjected to the similar FTAI and assigned to be treated with EB (n = 243) or E2+P4 (n = 224). Pregnancy diagnosis was performed 30 days after FTAI by ultrasonography. The day to emergence of NFW was similar between treatments (EB: 3.7 ± 0.37 vs. E2+P4: 3.3 ± 0.3, P = 0.76). Females treated with E2+P4 presented greater (P = 0.06) follicular growth between the emergence and D9 (1.18 ± 0.07) than those treated with EB (0.97 ± 0.08). There was also a positive effect (P < 0.05) of E2+P4 on diameter of the dominant follicle on D9 (13.0 ± 0.6 vs. 10.9 ± 0.55) and blood perfusion of the follicle wall on D8.5 (49 vs. 40%). There was a treatment by parity category interaction effect on P/FTAI (P < 0.05). Treatment with E2+P4 was advantageous to P/FTAI of primiparous cows (E2+P4: 58% and EB: 30%). However, for nulliparous and pluriparous cows, P/FTAI was similar between treatments (∼50%). In conclusion, in a E2/P4-based protocol for FTAI, E2+P4 is as efficient as EB in inducing new follicular emergence within a similar day range, but it results similar or greater P/FTAI.

Lack of effect of melatonin on ovarian function and response to estrous synchronization and fixed-time AI during the nonbreeding season in lactating dairy buffalo (Bubalus bubalis).

The present study was conducted to examine whether pretreatment with melatonin would enhance ovarian follicular functions and increase response to estrous synchronization and fixed-time AI (TAI) during the nonbreeding season in lactating dairy buffalo. In Experiment 1, buffalo cows without a detectable corpus luteum (CL) were assigned on Day -20 (D-20) to three groups: control (n = 12); melatonin (n = 13); progesterone (P4) (n = 15). Cows in the melatonin group were implanted with melatonin on D-20. From D0 to D9, there was imposing of an estrous synchronization treatment regimen using either a standard Ovsynch protocol (control, melatonin) or a P4-based Ovsynch treatment regimen (P4). There were no differences (P > 0.05) among groups for the presence of a CL at D0, size of the largest follicle at D0, ovulation to GnRH injection at D0 and D9, or the time to ovulation after injection of GnRH at D9. In Experiment 2, there was imposing of the same treatment regimens as in Experiment 1, with inclusion of TAI. Females of the P4 group had a greater (P = 0.001) pregnancy/AI percentage (60 %) than those in the control (17 %) and melatonin (23 %) groups. Females of the P4 group also had a larger (P = 0.005) CL at D20 compared with those in the control and melatonin groups. Findings indicate treatment with melatonin for 20 days did not affect ovarian functions or the response to an estrous synchronization treatment regimen and TAI during the nonbreeding season in lactating dairy buffalo.

Applied use of interferon-tau stimulated genes expression in polymorphonuclear cells to detect pregnancy compared to other early predictors in beef cattle.

We aimed to evaluate the accuracy of Interferon-tau stimulated genes (ISG) abundance in peripheral blood polymorphonuclear cells (PMNs) on D20 after fixed-time artificial insemination (FTAI; D0) as a pregnancy diagnosis method against CL evaluation by Doppler ultrasonography and progesterone (P4) concentrations on D20, as well as Pregnancy Associated Glycoproteins (PAG) concentrations on D25. Additionally, we evaluated the potential of ISG abundance in PMNs as pregnancy loss predictors. Nelore heifers (n = 103) and cows (n = 144) underwent estrous synchronization and were artificially inseminated on D0. Pregnancy was diagnosed by B-mode ultrasonography on D30 and D70, and after the final diagnosis, females were classified in four groups: Pregnant; Non-pregnant; Functional CL on D20 but non-pregnant (CL-NP) and Pregnancy loss between D30 and D70 (PL). After determining cutoff values, the Sensitivity (SE), Specificity (SP), Positive Predictive Value (PPV), Negative Predictive Value (NPV) and Accuracy (ACC) were determined for each method. All methods were classified as significant (P < 0.05) predictors of pregnancy. Both ISG expression and PAG concentrations were greater (P < 0.05) in pregnant females than in non-pregnant and CL-NP females but did not differ (P > 0.05) from the PL group. ISG15 expression was greater (P < 0.05) in heifers than in cows, but this difference was not found in OAS1 expression and PAG concentrations. All the methods evaluated were proven to be adequate predictors of pregnancy, but greater accuracies were obtained through PAG concentrations and Doppler-US, due to the decreased number of false positive and false negative results.

A novel strategy for resynchronization of ovulation in Nelore cows using injectable progesterone (P4) and P4 releasing devices to perform two timed inseminations within 22 days.

We aimed to evaluate the reproductive performance of Nelore lactating cows submitted to a resynchronization 12 days after timed artificial insemination (TAI) with or without a long-acting progesterone (P4-LA) treatment. Nelore cows were submitted to a P4/oestradiol-based TAI protocol (D0 = insemination). On D12, cows in the control group (n = 184) received a new P4 intravaginal device (0.96 g), whereas cows in the P4-LA group (n = 192) received the P4 device and 75 mg P4-LA. Cows identified as non-pregnant (n = 120) by regression of corpus luteum using colour Doppler ultrasonography on D20 had the P4 device removed and received 500ug of sodium cloprostenol, 1 mg of oestradiol cypionate and 300 IU of eCG and were re-inseminated on D22. There was no difference (p > 0.10) in the pregnancy rate at D20, D30 and D60 after first TAI between the control (69%, 59.7% and 57%, respectively) and P4-LA (67%, 55.7%, and 55.2%, respectively) groups. Pregnancy losses were similar between both groups (p > 0.1). For cows submitted to the second TAI, the pre-ovulatory follicle size did not differ (p > 0.1), but the oestrous detection and pregnancy rates were greater (p < 0.05) in the P4-LA group (92.2% [59/64] and 60.9% [39/64], respectively) than in controls (75% [42/56] and 44.6% [25/56]). The cumulative pregnancy rate after two TAIs did not differ (p > 0.1) between control (73.3% [135/184]) and P4-LA (76% [146/192]) groups. The use of P4-LA at 12 days after TAI potentially increases the pregnancy rates for a new early resynchronization strategy associated with the Doppler imaging for pregnancy diagnosis and results in an alternative to perform two TAIs in 22 days in beef cows.

Assessment of the usage of biodegradable polymeric matrix in vaginal devices to sustain progesterone release in cows.

The usage of timed artificial insemination (TAI) at a low cost leading to better reproductive rates has been the aim of several research groups in the field. Usually during TAI protocols, sustained progesterone (P4 ) release devices are employed. Most devices are constituted of a nylon skeleton covered with a silicon layer with P4 . A device based on biopolymers was developed in order to reduce costs and decrease its environmental impact. In this study, we compared the kinetics of sustained progesterone release among devices manufactured with a polymeric blend made of polyhydroxybutyrate-valerate (PHBV) and poly-ε-caprolactone (PCL) (DISP) which were compared with DIB® (Internal Bovine Device) used as the control. In the in vitro and in vivo progesterone release tests, two types of biopolymer-based devices with a superficial area of 147 cm2 were used: DISP8 (46% PHBV, 46% PCL and 8% P4 ; n = 4), DISP10 (45% PHBV, 45% PCL, 10% P4 ; n = 4) and DIB® (1 g P4 , 120 cm2 area; n = 3). The in vitro tests were carried out according to USP XXIII specifications and were performed in a dissolutor sink using an alcohol/water mixture (60/40 v/v) as a release media and samples were collected at 2 min, 2, 4, 8, 12, 24, 48, 60, 72, 84 and 96 h. P4 concentrations were measured through spectrophotometry in a 244 nm long wave. Three to 3 comparisons of angular coefficients of the straight lines obtained by regression analysis of accumulated P4 concentrations as a function of square root of time were carried out. Furthermore, the diffusion coefficient values of P4 were also determined for DISP8 and DISP10. The results showed that the concentrations of P4 were higher in the DISP10 (774.63 ± 45.26 µg/cm2 /t1/2 ) compared to DISP8 (566.17 ± 3.68 µg/cm2 /t1/2 ) (P < 0.05). However, both DISP10 and DISP8 P4 concentrations did not differ from DIB® (677.39 ± 16.13 µg/cm2 /t1/2 ). For the analysis of released quantities per day of the in vitro test, four periods were considered: 0-24, 24-48, 48-72 and 72-96 h. In the first 24 h, DISP8 released significantly less P4 than DISP10 or DIB®, which did not differ among them. Between 24 and 48 h, DISP10 released significantly more P4 than DIB®. DISP8 released an intermediate P4 amount and did not differ significantly from DIB® or DISP10. Between 48 and 72 h, P4 quantity released by DISP10 was significant higher (P < 0.01) than that of DIB® and DISP8, which did not differ among themselves. Between 72 and 96 h, DISP10 released significantly more P4 than DIB®, and DISP8 released an intermediate amount which did not differ from DIB® or DISP10 (P < 0.01). There was interaction between treatment and time (P = 0.0024). The diffusion coefficient values were: 1.36 × 10-8 (cm2 /s) for DISP10 and 1.12 × 10-8 (cm2 /s) for DISP8. For the in vivo test, ovariectomized crossbred cows received DIB® (n = 4) or DISP8 (n = 8) in an alternate design with a non-balanced sequence (cross-over) added of measures repeated in time referring to 16 days of blood samples collection. Samples were analyzed through radioimmunoassay in solid phase using the commercial kit of DPC (Diagnostics Products Corporation). Plasma concentrations of P4 peaked at 4 h after the placement of the device, this being the only time in which plasma P4 concentrations differed between DIB® (11.45 ± 1.96) compared with DISP8 (9.23 ± 1.15 ng/mL) (P = 0.027). On day 8, plasma P4 concentrations were similar for DIB® (2.44 ± 0.09) and DISP8 (1.89 ± 0.13 ng/mL) (P = 0.58) showing that both devices were able to keep P4 concentrations above 1 ng/mL in the plasma of the cow during the 16 day in vivo test. In conclusion, devices manufactured with the blend of PHBV/PCL biopolymers can sustain the release of P4 in a similar manner as silicon.

Use of FSH in two different regimens for ovarian superstimulation prior to ovum pick up and in vitro embryo production in Holstein cows.

We aimed with the present study to evaluate the effects of FSH treatment (200 mg) split in four or six administrations on ovarian follicle stimulation and in vitro oocyte competence for embryo production in dairy cows with synchronized follicular wave emergence. On random days of the estrous cycle (Day 0), non-lactating Holstein cows received a progesterone (P4)-releasing intravaginal device and 2 mg estradiol benzoate IM. On Day 3, they received 0.530 mg sodium cloprostenol (PGF2α) IM. Control cows (n = 35) received no further treatments, whereas FSH-treated cows received 200 mg FSH split in four (FSH4 group; n = 33) or six (FSH6 group; n = 33) administration regimens. Starting on Day 4, cows in FSH4 group received 200 mg FSH split in four equivalent doses of 50 mg 12 h apart. Cows in FSH6 group received the same total FSH dose split in six equivalent doses of 33.3 mg 12 h apart, but treatments started on Day 3. On Day 7 AM (36 h of "coasting" period for FSH-treated groups), the P4 devices were removed and cows were subjected to ovum pick up (OPU). Viable oocytes were in vitro fertilized using sexed-sorted semen. Although FSH treatment did not (P > 0.1) increase the total number of follicles (Control, 53.2 ± 4.5 vs. FSH-treated, 51.4 ± 3.1), the two hormonal stimulation regimens, FSH4 and FSH6, increased the number of medium follicles (6-10 mm; 5.2 ± 0.5 vs. 18.1 ± 1.4; P < 0.0001) and reduced the number of small follicles (2-5.9 mm; 46.3 ± 5.1 vs. 31.0 ± 2.4 P < 0.0001). Also, FSH treatment or regimen did not increase (P > 0.1) the number of viable oocytes (Control, 12.6 ± 1.26 vs. FSH-treated, 12.70 ± 1.03), recovery rate (Control, 36.5% vs. FSH-treated, 36%) and the number of in vitro produced blastocyst (Control, 4.1 ± 0.52 vs. FSH-treated 4.3 ± 0.5). We concluded that FSH stimulation protocol proposed herein is effective to stimulate the growth of small antral follicle population prior to OPU, but it was ineffective to improve in vitro oocyte competence for embryo production in non-lactating Holstein cows with synchronized follicular wave emergence.

Pathogenicity of Nc-Bahia and Nc-1 strains of Neospora caninum in experimentally infected cows and buffaloes in early pregnancy.

Neospora caninum is a protozoan parasite known as an important cause of bovine abortion worldwide. Little is currently known about how different strains of N. caninum vary in their pathogenicity. In this study, we compared a Brazilian strain, Nc-Bahia, with the first isolate of this coccidian, Nc-1. Eight cows and seven buffaloes were submitted to fixed-time artificial insemination protocols for a better control of pregnancy. Group 1 was inoculated with Nc-Bahia (n = 8; five cows and three buffaloes), and Group 2 was inoculated with Nc-1 (n = 5; two cows and three buffaloes). One nonpregnant female of each species was left uninfected as sentinel controls for potential environmental infection. All inoculated animals received 5 × 10(8) tachyzoites of N. caninum, by intravenous route, on the 70th day of gestation. Uninfected animals remained seronegative throughout the experiment, indicating no exogenous infection, whereas all inoculated animals became seropositive to N. caninum. In Group 1, abortion was found in only one cow on 42 days postinfection (dpi; frequency of abortion = 12.5%), whilst all animals from Group 2 aborted on 35 dpi (frequency of abortion = 100%). Parasite DNA was detected by seminested PCR in maternal, foetal and placental tissues, confirming vertical transmission in Groups 1 and 2, although histological lesions had different frequencies and degrees of severity between the groups. There was evidence of lower pathogenicity of Nc-Bahia compared to Nc-1 when used in experimental infection, as it caused fewer abortions, as well as less frequent and milder histological lesions. This was the first time Nc-Bahia has been used for experimental infection.

Development of poly(lactic acid) nanostructured membranes for the controlled delivery of progesterone to livestock animals.

Solution blow spinning (SBS) is a novel technology feasible to produce nanostructured polymeric membranes loaded with active agents. In the present study, nanofibrous mats of poly(lactic acid) (PLA) loaded with progesterone (P4) were produced by SBS at different P4 concentrations. The spun membranes were characterized by scanning electron microscopy (SEM), differential scanning calorimetry (DSC) and Fourier-transform infrared spectroscopy (FTIR). The in vitro releasing of P4 was evaluated using high-performance liquid chromatography (HPLC). Interactions between progesterone and PLA were confirmed by rheological measurements of the PLA/P4 solutions and in the spun mats by microscopy (SEM), thermal (DSC) and spectral (FTIR) analyses. SEM micrographs provided evidences of a smooth and homogeneous structure for nanostructured membranes without progesterone crystals on fiber surface. FTIR spectroscopy indicated miscibility and interaction between the ester of PLA and the ketone groups of the P4 in the nanofibers. X-ray analysis indicated that the size of PLA crystallites increased with progesterone content. Finally, by in vitro release experiments it was possible to observe that the progesterone releasing follows nearly first-order kinetics, probably due to the diffusion of hormone into PLA nanofibers.

Efeito do eCG ou benzoato de estradiol associado ao norgestomet na taxa de concepção de vacas de corte submetidas à IATF no pós-parto / Effect of eCG or estradiol benzoate associated with norgestomet on the conception rate of beef cows submitted to FTAI in the postpartum

Este estudo objetivou comparar as taxas de concepção, em vacas de corte no período pós-parto (PPP), tratadas com Gonadotrofina Coriônica Eqüina (eCG) ou Benzoato de Estradiol (BE), após o uso de Norgestomet submetidas à inseminação artificial em tempo fixo(IATF). A hipótese é que a administração de eCG ou BE aumenta as taxas de concepção. Vacas Nelore (n=138) e Brangus (n=63), lactantes,entre 26 e 118 dias do PPP, foram divididas em três grupos homogêneos e dentro de cada grupo subdivididas em dois blocos, um com um PPP < 45 dias (PPP1; n=107) e outro > 45 dias (PPP2;n=94). Todas as fêmeas receberam um implante auricular contendo 3mg de Norgestomet (Crestar®), seguido pela administração de 5mg de Valerato de Estradiol. Os implantes auriculares foram mantidos durante 10 dias. Na retirada dos implantes, as fêmeas receberam 1mL de solução fisiológica (n=68; Grupo Controle) ou 500 UI de eCG (Folligon®; n=67; Grupo eCG) ou 1mg de Benzoato de Estradiol (Index; n=66; Grupo BE) 24 horas após a retirada do implante. AIATF foi realizada 54 horas após a retirada do implante. O diagnóstico de gestação foi realizado por ultra- sonografia 30 dias após a IATF. Houve interação entre os tratamentos e o PPP. No PPP1, a taxa de concepção foi maior no grupo eCG comparado ao BE (47,22% vs.15,38%; P<0,01). No PPP2, as taxas de concepção dos grupos eCG eBE foram maiores que no grupo controle (41,93%, 44,44% vs.22,22%; P<0,01). Conclui-se que vacas, com até 45 dias do PPP, o eCG associado ao Norgestomet aumenta as taxas de concepção.

This study aimed to compare conception rates at the post partum period (PPP) in beef cows which were administered either Equine Chorionic Gonadotrophin (eCG) or Estradiol Benzoate (EB) after Norgestomet and submitted to fixed-time artificial insemination(FTAI). The hypothesis was that the administration of eCG or E Benhances the conception rate. Lactating Nelore cows (n=138) and Brangus (n = 63), between 26 and 118 days of post partum period(PPP) were divided into three homogeneous groups, and subdividedin two blocks, inside each group one of them with a PPP d” 45 days (PPP1; n=107) and another with a PPP > 45 days (PPP2; n=94). Allcows received an auricular implant containing 3mg Norgestomet(Crestar®), followed by the administration of 5mg Estradiol Valerate.The auricular implants were kept during 10 days. Cows received 1mL saline solution (n=68, Control Group) or 500IU eCG (Folligon®;n=67; eCG Group) or 1mg Estradiol Benzoate (Index, n=66; EB Group) 24 hours after the removal of the implant. FTAI was made 54 hours after the implant removal. The pregnancy diagnosis was carried through ultrasonography 30 days after FTAI. There was an interaction between treatments and PPP. In the PPP1, the conception rate was higher in the eCG Group than in the EB Group (47.22% vs.15.38%; Pd”0.01). In the PPP2, the conception rates of the eCG and EB Groups were higher than in the Control Group (41.93%, 44.44%vs. 22.22%: Pd”0.01). It was concluded that in cows up to 45 days of PPP, the eCG associated with Norgestomet enhances the conception rates.

Características seminais de ovinos suplementadosou não com uréia e diferentes fontes de enxofre / Seminal characteristics of rams supplement or not with urea and two sources of sulphur

Doze carneiros machos adultos mestiços Santa Inês de mesma idade e porte semelhante foram empregados em um delineamento inteiramente casualizado, por um período experimental de 60 dias. Os animais foram distribuídos para três tratamentos: A. 100% das exigências em proteína degradável no rúmen (controle); B. 100% das exigências em proteína degradável no rúmen + 3% de uréia + enxofre(99% S) e C. 100% das exigências em proteína degradável no rúmen +3% de uréia + enxofre quelatado (21,5% S). Semanalmente foram colhidas amostras de sêmen obtidas com emprego de vagina artificial e de sangue para determinação da concentração de nitrogênio uréico plasmático, assim como realizadas pesagens dos animais e aferições de circunferência escrotal. No sêmen foram analisados: volume e turbilhonamento; vigor, motilidade e concentração espermática; totalde espermatozóides e total de espermatozóides viáveis no ejaculado; integridade de membrana e de acrossoma; morfologia espermática e concentração de nitrogênio uréico no plasma seminal. Os animais suplementados com uréia apresentaram níveis de N-uréico no plasma sanguíneo e seminal significativamente maiores que os encontrados nos do tratamentos controle (p<0,05). Houve diferença significativa entre as fontes de enxofre utilizadas (p<0,05) quanto às características do sêmen estudadas, o tratamento C apresentando valores maiores para turbilhonamento (4,57), motilidade espermática (85,69%), vigor espermático (4,66) e total de espermatozóides por ejaculado (9,02 x109), além de uma porcentagem inferior de defeitos menores (5,37%)quando comparado ao tratamento B

Twelve adult Santa Inês crossbred rams with similar weight and age employed in a randomized design for 60 days period to evaluate three treatments: A. 100% of degradable protein requirement (control); B.100% of degradable protein requirement + 3% urea + inorganic sulphur (99%S) and C. 100% of degradable protein requirement+3% urea + organic sulphur (21,5% S). Every week seminal collections were made through artificial vagina; blood collections were made toanalyze plasma N-ureic levels and measured live weight and scrotal circumference. In semen samples were studied volume, microscopic waves, vigor, motility, concentration, total sperm per ejaculate, total feasible sperm per ejaculate, membrane sperm integrity, acrosomal integrity, percent of abnormal spermatozoa and N-ureic level in seminal plasma. Treatments experimental animals receiving presented blood and seminal plasma N-ureic levels higher than the ones of control treatment (p < 0,05). There was significant difference between organicand inorganic sources of sulphur in the following semen characteristics (p < 0,05): treatment C presented microscopic waves (4,57), motility(85,69%), vigor (4,66) and total sperm per ejaculate (9,02 x 109) higher than treatment B; and the percentage of secondary sperm abnormality (5,37%) was lower than treatment B

Taxas de serviço, concepção e prenhez de vacas nelore tratadas com gonadotrofina coriônica humana e 17?-estradiol após a inseminação artificial em tempo fixo / Service, conception and pregnancy rates of nelore cows treated with human corionic gonadotropin and estradiol-17? after timed artificial insemination

Avaliaram-se estratégias para reduzir a mortalidade embrionária em bovinos. Vacas Nelore (Bos taurus indicus) foram inseminadas em tempo fixo (IATF - D0) após o protocolo GnRH/PGF2a/GnRH e divididas nos grupos: Controle (Gc; n=55), hCG (GhCG; n=55) recebeu 3000 UI da hCG no D5 , E2 (GE2; n=55) recebeu 5 mg de 17?-Estradiol (E2) no D12 e hCG/E2 (GhCG/E2; n=55) recebeu 3000 UI da hCG no D5 e 5mg do E2 no D12. A IATF foi o 1o dia da estação de reprodução de 64 dias. Usou-se o teste do c2 para comparar as taxas de serviço (TS), concepção (TC) e prenhez à IATF (TPIATF), às IAs de repasse e acumuladas. A TS e a TC das IAs de repasse não diferiu (P>0,10). Houve diferenças nas TPIATF (P<0,05), pois a TPIATF do GE2 (5,4%) foi a mais baixa e a do Gc (34,5%) e GhCG (36,5%) tenderam (P<0,10) ser maiores que a do GhCG/E2 (18,2%). Não houve efeito da hCG sobre as taxas de prenhez. O E2 reduziu a TPIATF e ao final da estação as vacas que receberam o E2 (GE2 + GhCG/E2) tiveram TPacum (66,4%) mais baixa (P<0,05) de que aquelas (80,9%) que não receberam (GC + GhCG). Em conclusão, as estratégias adotadas de manipulação luteínica ou folicular não aumentaram as taxas de prenhez em vacas Nelore após uma IATF.

Strategies to reduce embryo mortality in cattle have been evaluated. Nelore (Bos taurus indicus) cows were submitted to timed artificial insemination (TAI - D0) after a GnRH/PGF2a/GnRH protocol. Cows were divided in the following groups: Control (Gc; n=55), hCG (GhCG; n=55) received 3000 IU of hCG on D5 , E2 (GE2; n=55) received 5 mg of Estradiol-17b (E2) on D12 and hCG/E2 (GhCG/E2; n=55) received hCG on D5 and E2 on D12. TAI represented the 1st day of a 64 day breeding season. The c2 test was applied to compare mating rate (MR), conception rate (CR) and pregnancy rate (PR) to TAI and AIs after natural estrus within the season as well as their accumulated figures at the end of the season. MR and CR for AIs within season did not differ (P>.10). PR to TAI differed (P<.05) among groups. GE2 showed the lowest rate (5,4%). Gc (34.5%) and GhCG (36.5%) tended (P<.10) to be higher than GhCG/E2 (18.2%). There was no effect of hCG on pregnancy rates. E2 reduced PR to TAI and at the end of season which means that cows receiving E2 (GE2 + GhCG/E2) had lower (66.4%; P<.05) PR than cows not receiving E2 (GC + GhCG; 80.9%). In conlusion, the strategies to manipulate luteal and follicular function herein tested did not increase pregnancy rates in Nelore cows submitted to a TAI.

Avaliação da reutilização de implantes auriculares contendo norgestomet associados ao valerato ou ao benzoato de estradiol em vacas nelore inseminadas em tempo fixo / Evaluation of norgestomet auricular implants reused associated to valerate or to estradiol benzoate in fixed time artifical insemination in Nelore cows

Em fêmeas bovinas a utilização da técnica de inseminação artificial em tempo fixo (IATF) é possibilitada pelo emprego de fármacos que tem como objetivos sincronizar a emergência das ondas foliculares, os estros e a ovulação. Em rebanhos comerciais, o custo de tais fármacos deve estabelecer uma vantajosa relação com os benefícios. O presente estudo, objetivou comparar as taxas de prenhez em vacas Nelore (Bos taurus indicus) inseminadas em tempo fixo, tratadas com implantes auriculares contendo 3mg de norgestomet (Crestar®), novos (IN) ou utilizados uma vez (IR; reutilizados), associados a administração de norgestomet (NG) e valerato de estradiol (VE) ou progesterona (P4) e benzoato de estradiol (BE). Vacas Nelore PO (n=241), amamentando, com o bezerro ao pé, receberam um dos quatro tratamentos: Crestar® novo durante 10 dias associado a administração de 3mg de NG e 5mg de VE (grupo IN/NG+VE; n=61); Crestar® novo inserido durante 8 dias associado a 50mg de P4 e 2mg de E (grupo IN/P4+BE; n=61); Crestar® reutilizado inserido durante 10 dias associado a administração de 3mg de NG e 5mg de VE (grupo IR/NG+VE; n=58) ou Crestar® reutilizado inserido durante 8 dias associado a e 50mg de P4 e 2mg de BE (grupo IR/ P4+BE; n=61). No dia da remoção dos implantes os animais receberam 7,5mg de Luprostiol e 24 horas após a remoção 1mg de BE. A IATF foi realizada 54 a 56 horas após a retirada dos implantes. Após a IATF, as vacas tiveram os estros observados durante um período de 49 dias e em estro foram reinseminadas 12 horas após a observação. O diagnóstico de gestação foi realizado por ultra-sonografia 35 dias após a IATF e após o final da estação de monta. Foram avaliadas as taxas de prenhez na IATF (TP IATF) e no final da estação de monta (TP EM). Não houve interação entre as características dos implantes (novos e reutilizados) e os tratamentos administrados no dia da inserção do implante (NG+VE e P4+BE). A utilização do CIDR® novo ou reutilizado não teve...

The use of fixed -time artificial insemination (IATF) in cows is possible by the use of drugs that aim at the synchronization of the folicular wave pool, the estrus and ovulation. In trading cattle the costs of these drugs must stablish a profitable relation with the benefits. The present study meant to compare the pregnancy rates in Nelore (Bos taurus indicus) cows inseminated at fixed-time, treated with new (IN) or once used (IR; reused) auricular releasing devices with 3mg of norgestomet (Crestar®), associated with the administration of norgestomet (NG) and estradiol valerate (VE) or progesterone (P4 and estradiol benzoate (BE). Pure breed Nelore cows (n=241), on lactation with calf received one of the four treatments: new Crestar® during 10 days administrated with 3mg of NG and 5 mg of VE (group lN/NG+VE; n=61); new Crestar® inserted during 8 days with 50mg of P4 and 2mg of BE (group lN/P4 +BE; n=61); reused Crestar® inserted during 10 days in association with 3 mg of norgestomet and 5 mg of VE (group IR/NG+ VE; n=58) or reused Crestar® inserted during 8 days in association with 50mg of P 4 and 2mg of BE (group lR/P4+BE; n=61). On the day the releasing devices were removed the animals received 7,5mg of Luprostiol and after 24 hours 1mg of BE. A fixed-time artificial insemination was done 54 to 56 hours after the removal of the releasing devices. Cows detected in estrus after the insemination at fixed-time were observed during a period of 49 days and reinseminated. The pregnancy diagnosis was done by ultrassonography 35 days after the IATF and after the end of the breeding season. The pregnancy rates of IATF (TPIATF) and at the end of the breeding season (TP EM) were estimated. There was no interaction between the characteristics of the (new or reused) releasing devices and the treatment given at the day the releasing devices were inserted (NG+ VE e P4 + BE). The use of new or used CIDR® had no effect on TP IATF (48,3%vs 48,7%) and on TP EM (85)...

Influência do glicerol e etilenoglicol e da criopreservação sobre o complexo DNA-Proteina de espermatozóides em garanhões / Glycerol, ethyleneglycol and cryopreservation influences on semen an sperm DNA-Protein complex in stallion

O processo de criopreservação causa estresse físico e químico aos espermatozóides, acarretando alterações bioquímicas, diminuição irreverssível da motilidade espermática, aumento da degeneração do DNA e liberação intracelular de enzimas e lipídeos. No presente estudo, foram estudadas a influência das estações não reprodutiva e reprodutiva, dos crioprotetores glicerol e etilenoglicol e do processo de congelação e descongelação sobre o complexo DNA-proteína de espermatozóides em garanhões. Foi comparados o sêmen puro, o sêmen puro e congelado sem crioprotetores, o sêmen diluído e exposto aos crioprotetores sem congelação e o sêmen diluído e congelado com crioprotetores. Foram utilizados seis garanhões, colhendo 12 ejaculados cada. A patologia do complexo DNA-Proteína foi avaliada em espermatozóides fixados com etanol-ácido-acético glacial 3: 1 (v/ v), tratados com HCL 4N a 25°C e corados com azul de toluidina a 0,025% em tampão McIlvaine, empregando microscopia óptica com aumento de 1000x. Os resultados mostraram que a anomalia do complexo DNA-Proteína dos espermatozóides diferem entre os grupos congelados e não congelados (P<0,05). O sêmen congelado sem crioprotetor não apresentou aumento significativo de patologia do complexo DNA-Proteína em relação ao sêmen congelado com crioprotetores, mas ambos mostraram aumento em relação ao sêmen puro ou diluído e exposto aos crioprotetores. A influência da estação reprodutiva mostrou diferença significativa (P<0,05) somente no sêmen puro e no sêmen puro e congelado sem crioprotetor. Conclui-se que o processo de congelação exerce influência negativa sobre o complexo DNA-Proteína de espermatozóides em garanhões.

The cryopreservation process cause stress physical and chemical to the spermatozoa, causing biochemistry alteration, irreversible reduction of the spermatic motility, increase of the DNA degeneration and intracellular enzyme and lipids release. The aim of this study was to evaluate the influence of non-breeding and breeding seasons, glycerol and ethylene glycol, cryopreservation and thawing processes on stallion spermatozoa DN A -protein complexo It was compared fresh semen, diluted semen frozen without cryoprotectants, diluted semen exposured to cryoprotectants but not frozen and d) diluted semen frozen with cryoprotectants. Six stallions had 12 semen collections each. DNA-protein complex pathology was assessed by optical microscopy (1000x) using spermatozoa treated with ethanol-acetic acid 3:1 (v/v), HCl 4N at room temperature and toluidin blue 0,025% in McIlavaine buffer. Results showed that DNA-protein complex were different between frozen and not frozen spermatozoa groups (P<0,05). Frozen semen without cryoprotectants had no increasing of DNA-protein complex pathology compared to semen cryopreserved with cryoprotectant, but both showed increasing in relation to fresh and diluted semen exposured to cryoprotectants. The influence of non breeding and breeding season showed significant difference (P<0,05) in the fresh semen and fresh semen frozen without cryoprotectants. Cryopreservation process had negative influence on spermatozoa DNA-protein complex.

Mecanismos endócrinos e moleculares envolvidos na formação do corpo lúteo e na luteólise - revisão de literatura / Endocrine and molecular mechanisms involved in the formation of corpus luteum and luteolysis - A Review

O corpo lúteo (CL) é uma estrutura endócrina transitória formada por células luteais esteroidogênicas pequenas (SLC) e grandes (LLC), que associadas aos fibroblastos e a uma ampla rede de capilares constituem uma estrutura especializada na síntese de progesterona (P4). De maneira geral, para a síntese de P4 nas células luteais esteroidogênicas, o colesterol se liga a receptores específicos na membrana celular e é transportado ao citosol. Posteriormente, o colesterol dirige-se a membrana mitocondrial interna e por ação da enzima P450scc transforma-se em pregnenolona. No retículo endoplasmático liso a pregnenolona é convertida a P4 pela enzima 3β-hidroxiesteróide deidrogenase (3β-HSD). A proteína de regulação aguda da esteroidogênese (StAR), o receptor benzodiazepínico tipo periférico (PBR) e a endozepina participam no transporte do colesterol para os diferentes compartimentos mitocondriais. Assim, supõe-se que a capacidade de síntese de P4 no CL esteja relacionada à concentração celular de receptores que captam o colesterol, às enzimas P450scc e 3β-HSD, e às proteínas celulares transportadoras de colesterol. Na espécie bovina, as LLC são responsáveis por mais de 80% da produção deste hormônio no CL. A menor concentração de proteínas transportadoras de colesterol na mitocôndria parecem limitar a síntese de P4 nas SLC. A P4 favorece um meio ambiente uterino apropriado para o desenvolvimento do(s) concepto(s), dependendo da espécie. Na maioria das espécies, a ausência da fertilização ou a incapacidade do concepto em sinalizar sua existência no útero estabelecem a luteólise. Tal evento fisiológico caracteriza-se pela regressão funcional e estrutural do(s) corpo(s) lúteo(s). Para o estabelecimento e a manutenção da prenhez torna-se necessário o bloqueio da luteólise por mecanismos que diferem entre as espécies. Em primatas e equídeos esse reconhecimento ocorre pela secreção de gonadotrofinas específicas e em ruminantes pela presença de fatores ...

The corpus luteum (CL) is a transitory endocrinal structure formed by steroidogenic small luteal cells (SLC) and large luteal cells (LLC) that associated with fibroblast and a wide web of capillaries form a structure specialized in synthesis of progesterone (P4) In general, for the synthesis of P4 in the steroidogenic luteal cells, cholesterol joints specific receptors on the cellular membrane and is transported to the cytosol. Later, cholesterol goes to an internal mitochondrial membrane and by the action of the enzyme P450scc is transformed into pregnenolone. In the smooth endoplasmic reticulum pregnenolone is converted to P4 by the enzyme 3β-hydroxysteroid dehydrogenase (3 β -HSD). The steroidogenic acute regulatory protein (StAR), the peripheral benzodiazepine receptor (PBR) and endozepine participate in the transport of cholesterol to the different mitochondrial compartments. Therefore, it is supposed that the capacity of synthesis of P4 in the CL is related to the cellular concentration of receptors that catch cholesterol, to the enzymes P450scc and 3β-HSD and to the cholesterol cellular transport proteins. In bovine, the LLC are responsible for more than 80 of P4 production in the CL. The lowest concentration of cholesterol transport proteins in the mitochondria seems to limit the synthesis of P4 in the SLC. P4 supports a proper uterine environment for the development of conceptuses, depending on the specie. In most species, the lack of fertilization or the conceptus incapacity to signalize its presence in the uterus establishes luteolysis. This physiolocal event is characterized by the functional and structural regression of the CL. For the establishment and maintenance of pregnancy it is necessary to block luteolysis through different mechanisms among species. In primates and equids it occurs by the secretion of specific gonadotropins and in ruminants by antiluteolytic factors. This review has the objective to characterize the endocrine ...

Caracterização do estro de novilhas cruzadas (Bos taurus indicus x Bos taurus taurus) por radiotelemetria / Estrous characterization in cross-bred heifers (Bos taurus indicus X Bos taurus taurus) by radiotelemetry

Embora a técnica de inseminação artificial (IA) apresente inúmeras vantagens, no Brasil é empregada em apenas 7% das fêmeas de corte. Falhas na detecção de estros constituem o principal fator limitante para a obtenção de êxito no emprego da técnica. Um sistema eletrônico, que se baseia na radiotelemetria, foi desenvolvido para a detecção de estros. Este sistema fornece o registro da data, horário e duração das montas ocorridas. O presente estudo teve como objetivo avaliar, pelo sistema de radiotelemetria, as características comportamentais de estro em novilhas cruzadas de corte (Bos taurus taurus x Bos taurus indicus), criadas em regime extensivo, na região sudoeste do Brasil. A hipótese testada foi que a duração dos estros e o número de montas são bastante variáveis entre as fêmeas e que a maioria das montas ocorre no período noturno. Para a sincronização dos estros as novilhas receberam 0,5mg de MGA/cabeça/dia, uma vez ao dia, durante 8 dias, e uma injeção de 15mg de luprostiol (PG) via IM no último dia da ingestão de MGA. Os estros foram registrados pelo sistema de radiotelemetria "Heat-Watch", durante um período de até 120 horas após a aplicação de PG. A duração média dos estros foi de 10,4 ± 5,7 horas, duração que variou de 45 minutos a 22,7 horas. O número médio de montas foi de 26,2 ± 13,6 e variou de 3 a 81 montas. A duração média das montas foi de 2,7 ± 0,3 segundos. Dransfield et al. classificaram os estros em curta (< 7 horas) e longa (≥. 7 horas) duração e baixa (< 1,5 montas/hora) e alta (≥ 1,5 montas/hora) intensidade. Houve uma maior incidência dos estros de longa duração quando comparados aos de curta duração (72,8% vs. 27,2%; P<0,05) e uma maior incidência dos estros de alta intensidade quando comparados aos de baixa intensidade (70,2% vs. 29,8%; P<0,05). A média geral de montas diurnas foi de 10,0 ± 9,7 (das 7:00 às 19:00 horas) e de montas noturnas de 13,0 ± 12,4 (das 19:00 às 7:00 horas), sendo que não foi observado efeito de ...

Although artificial insemination (AI) has countless advantages, in Brazil this technique is performed in only 7% of beef cattle. Failures on estrous detection are the main limiting factor to the success of this technique. An electronical system, based on radiotelemetry, was developed for estrous detection. This system provides day, hour and service length. The present study aimed to evaluate by radiotelemetry system the behavioral characteristics of the estrous of crossbred heifers (Bos taurus taurus x Bos taurus indicus) raised at pasture regimen in southwest.

Uso do hCG, GnRH ou 17beta-Estradiol e progesterona associados ao acetato de melengestrol e prostaglandina f2alfa em novilhas cruzadas (Bos taurus indicus x Bos taurus taurus) / Use of hCG, GnRH or 17beta-estradiol and progesterone associated with melengestrol acetate and prostaglandin F2alfa in cross-bred heifers (Bos taurus indicus x Bos taurus taurus)

O objetivo do presente experimento foi avaliar a performance reprodutiva e as características de estros em novilhas cruzadas de corte (Bos taurus indicus x Bos taurus taurus) tratadas com o protocolo MGA/Prostaglandina (PG) em associação a outros hormônios. No dia 0 (Dia 0 = início da ingestão do MGA) as novilhas foram distribuídas ao acaso para receber 2mL de solução salina (grupo Salina), 2500UI de hCG (grupo hCG), 20müg de acetato de buserelina (grupo GnRH) ou 5mg de 17beta-estradiol + 100mg de progesterona (grupo 17beta-E2 +P4. Amostras de sangue foram colhidas nos dias - 7, 0, 7 e 10 para a mensuração das concentrações plasmáticas de progesterona. Independentemente do tratamento, todas as novilhas receberam 0,5mg MGA/ animal/ dia durante 8 dias (Dia 0 ao 7) e PG (Dia 7). Os estros foram observados durante 120h, a partir da injeção de PG, pelo sistema Heat- Watch. As novilhas foram inseminadas 12 horas após o início dos estros ou 72h depois da injeção de PG. O diagnóstico de gestação foi realizado 35 dias após a última inseminação, por ultrasonografia. As respostas em estros foram de 50,0%, 22,2%, 59,5% e 71,8% para os grupos Salina, hCG, GnRH e 17beta-E2 +P4, respectivamente (P< ou =0,01). O intervalo médio da injeção de PG ao estro foi de 72,8 + ou - 22,2, 102,0 + ou - 22,7,84,6 + ou - 19,0 e 72,5 + ou - 24,4 horas (P< ou =0,01), sendo o grau de sincronização similar entre os grupos. As taxas de concepção foram de 57,9%, 37,5%, 40,9% e 39,3% e as taxas de prenhez de 29,0%, 11,1 %,27,0% e 28,2%, para os grupos Salina, hCG, GnRH e 17beta-E2 +P4, respectivamente. Não houve efeito do tratamento na duração dos estros (10,4 + ou - 5,7 horas), número de montas (23,0 + ou - 16,9) e duração das montas (2,7 + ou - 0,3 segundos), sendo os valores entre parênteses correspondentes às médias gerais e desvios padrão. Em conclusão, a performance reprodutiva não foi alterada pela adição do hCG, GnRH ou 17beta-E2 +P4 ao protocolo de sincronização MGA/PG.

Existem relaçöes entre tamanho e morfoecogenicidade do corpo lúteo detectados pelo ultra-som e os teores de progesterona plasmática em receptoras de embriöes eqüinos? / Are there relationships between the luteal size, luteal morphoechogenicity by ultrasound and plasmatical progesterone concentrations in recipient mares?

O corpo lúteo (CL) é a glândula produtora de progesterona (P4), hormônio cuja secreçäo contínua é essencial para o início e a manutençäo da gestaçäo em fêmeas eqüinas, e, conseqüentemente, para a aplicabilidade de inúmeras biotécnicas de reproduçäo. Considerando-se a importância do CL para a manutençäo de uma gestaçäo normal e suas características anatomofisiológicas, objetivou-se determinar por ultra-sonografia (US) o tamanho e a morfoecogenicidade (ME) do CL em receptoras de embriöes eqüinos desde a ovulaçäo (D0) até nove dias após (D9), bem como os níveis plasmáticos de P4 produzida no mesmo período. Para tanto, 57 éguas receptoras de um programa de transferência de embriöes foram examinadas diariamente por US transretal desde a primeira detecçäo dos sinais de estro até o D9. A cada exame, os CL foram mensurados e sua ME registrada segundo escore de 1 a 6 (1=anecóico; 6=hiperecóico). Amostras de sangue foram colhidas diariamente e a P4 dosada por radioimunoensaio. O diagnóstico de gestaçäo foi realizado por US aos 13 e 25 dias após a ovulaçäo. Houve uma tendência de os corpos lúteos apresentarem ME crescente (de 1 a 5) desde o dia da ovulaçäo até o D9. Os níveis de P4 foram < 2,16 ng/ml até o D3, com conseqüente elevaçäo e manutençäo em níveis de diestro entre D4 e D9 (3,41 a 4,33 ng/ml). O tamanho luteínico näo diferiu, com exceçäo das médias extremas durante o período (D2 = 31,54 mm versus D8 = 25,95mm; p < 0,05). Assim, o aumento da ME média dos CLs avaliados por US é acompanhado por aumento na concentraçäo plasmática de P4 em receptoras de embriöes, mas este evento parece näo ser dependente do tamanho da glândula luteínica. Näo existe diferença na ME, no tamanho dos corpos lúteos, nem nos níveis de P4 circulante do D0 ao D9 em receptoras de embriöes eqüinos que se tornaram gestantes ou näo após a transferência de embriöes

Influence of the development phase of the dominant follicle on the superovulatory response in Nelore heifers

The aim of this study was to evaluate the influence of the dominant follicle during it's growing, static and regression phases on the superovulatory response in 18 estral cycles of nelore heifers. The follicular development was monitored by ultrasound from Day 6 to Day 10 (Day 0=estrus) of the oestrus cycle, when the diameter of the largest follicle was measured and the number of subordinate follicles counted. The animals where superovulated with 400 or 500IU of FSH/LH twice daily for 4 days begining on day 10 of the oestrus cycle I was injected PGF2(subscribe)a concomitantly with the fifth dose of FSH/LH. Artificial insemination was done 12 and 24 hours after the begining of the estrus. Embryos were recovered on day 6.5 after the first insemination. If a dominant follicle was present before superovulation, it was observed subordinate follicles atretic and low response to superovulatory treatment. The best result of transferable and total embryos was observed when the dominant follicle was in regression phase (3.67 and 10.17) at the beginning of the superovulatory treatment

Superovulaçäo de novilhas da raça Nelore com diferentes doses de FSH/LH e congelaçäo de embriöes pelo método one-step com etilenoglicol / Superovulation of Nelore heifers with different FSH/LH doses and embryo freezing by one-step method with ethylene-glycol

Este trabalho teve como objetivo identificar a dose mais eficiente de FSH/LH (300, 400 e 500 UI) no tratamento superovulatório de novilhas da raça Nelore, assim como avaliar o método one-step no processo de congelaçäo de embriöes. A variaçäo da resposta superovulatória tem sido muito grande, o que explica o interesse de diversos pesquisadores em encontrar novos hormônios, doses e momentos para realizar a estimulaçäo ovariana. Foram empregadas doses de 300 (n = 20), 400 (n = 21) ou 500 UI (n = 21) de FSH/LH, iniciando-se no décimo dia do ciclo estral, em 8 aplicaçöes decrescentes, durante quatro dias consecutivos. Foi aplicado PGF2(subscrito)a concomitante com a quinta subdose de FSH/LH e realizadas duas inseminaçöes artificiais às 12 e às 24 horas após o início dos sintomas de estro. As colheitas dos embriöes foram realizadas 6,5 dias após a primeira inseminaçäo artificial. Pelo exame ultra-sonográfico, avaliaram-se os números de folículos no momento da inseminaçäo artificial (15,12; 15,76; e 14,94) e de corpos lúteos (10,68; 11,55; e 10,81) no dia da colheita, encontrando 5,20; 1,81; e 2,76 embriöes viáveis, respectivamente, para 300 UI, 400 UI e 500 UI de FSH/LH. O grupo de 300 UI de FSH/LH apresentou os melhores resultados em relaçäo aos embriöes viáveis. Dos 106 embriöes congelados pelo método one-step em 1,5 M de etilenoglicol e transferidos pelo método nao-cirúrgico, 8 resultaram em prenhez (7,5 por cento). A dose de 300 UI de FSH/LH apresentou melhor resposta superovulatória em comparaçäo com as de 400 e 500 UI para novilhas da raça Nelore. A transferência de embriöes Bos taurus indicus congelados pelo método one-step em 1,5 M de etilenoglicol nao foi eficiente

Sincronizaçäo do estro em fêmeas bovinas da raça Nelore (Bos taurus indicus) com o uso de acetato de melengestrol associado ou näo à prostaglandina F 2 subscrito alfa / Estrus synchronization in Nelore females (Bos taurus indicus) using melengestrol acetate with or without prostaglandin F subscribe 2 alfa

Este trabalho foi realizado para determinar a eficácia do acetato de melengestrol (MGA) associado ou nao à prostaglandina F2(subscrito)a (PG), na sincronizaçäo do estro em fêmeas zebuínas da raça Nelore (Bos taurus indicus). Foram utilizadas 548 vacas e novilhas distribuídas, segundo idade, condiçäo corporal, sexo do bezerro e dias pós-parto, em três grupos. Grupo controle (n = 119): os animais deste grupo receberam suplemento mineral protéico sem o MGA. Grupo MGA (n = 219): receberam 0,5 mg MGA/cabeça/dia durante 14 dias. Grupo MGA/PG (n = 210): receberam 0,5 mg MGA/cabeça/dia durante 14 dias e uma dose de 25 mg de PG (IM), no 17§ dia após o último dia de ingestäo do MGA. A inseminaçäo artificial (IA) ocorreu 12 h após a detecçäo do estro. Ambos os tratamentos para sincronizaçäo do estro realizados, neste experimento, foram eficazes para se aumentarem as taxas de prenhez, nos dois primeiros períodos de avaliaçäo da estaçäo de monta, dos animais tratados em relaçäo aos näo-tratados (grupo MGA = 27,40 por cento; MGA/PG = 31,90 por cento vs controle = 17,65 por cento). Quanto a este aspecto, a aplicaçäo de PG proporcionou maior número de animais em estro, nos primeiros 5 dias de estaçäo de monta, o que facilitou sobremaneira a utilizaçäo da IA